During the period between 2023 and 2031, the global market for point-of-care molecular diagnostics is predicted to expand at a CAGR of 8.5%. The growth of the point-of-care molecular diagnostics market is primarily driven by the increasing prevalence of infectious diseases and cancer, as well as the growing demand among end users for point-of-care molecular testing due to its appealing ...
Read More »